A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction

NCT07269717 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure With Preserved Ejection Fraction

Interventions

DRUG: HRS-1893 Tablet
DRUG: HRS-1893 Tablet Placebo

Sponsor

Shandong Suncadia Medicine Co., Ltd.